TrialClinical ophthalmology (Auckland, N.Z.)2022

Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial.

Mark PackerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.